Brain Tumor, Refractory
2 clinical trials · Condition
◉ Watch Brain Tumor, Refractory
| Record | Firm | Date |
|---|---|---|
| Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors (NCT04023669) | St. Jude Children's Research Hospital | 2019-08-08 |
| T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors (NCT02442297) | Baylor College of Medicine | 2016-04-01 |
Track Brain Tumor, Refractory automatically
Every clearance here is in the API, with alerts when new ones post.